Results of implementation of a fast track pathway for diagnosis of colorectal cancer

Revista Espanola de Enfermedades Digestivas

Volumn 103, Issue 8, 2011, Pages 402-407

  Vallverdú Cartié, Helena ^a   Comajuncosas Camp, Jordi ^a   Orbeal Sáenz, Rolando A ^a   López Negre, José Luis ^a   Gris Garriga, Pedro J ^a   Jimeno Fraile, Jaime ^a   Hermoso Bosch, Judit ^a   Sanchez Pradell C ^a   Torra Alsina, Sandra ^a   Urgellés Bosch, Joan ^a   Parés, David ^a  

^a PARC SANITARI SANT JOAN DE DÉU   (Spain)

Author keywords

Colorectal cancer; Fast track diagnostic pathway; Surgical treatment

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; COLONOSCOPY; COLORECTAL CANCER; FAST TRACT DIAGNOSTIC PATHWAY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY;

EID: 80054679648     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082011000800003     Document Type: Article

References (38)

1. Globocan Study. International Agency for Research on Cancer. WHO. Available at: http://globocan.iarc.fr/ on line. September 2010.
2. Cabanes Domenech A, Pérez Gómez B, Aragonés N, Pollán M, López-Abende G. La situación del cáncer en España, 1975-2006. Instituto de Salud Carlos III. Madrid, 2009.
3. Estrategia y prioridades en cáncer en Cataluña. Plan Director de Oncología: Objetivos 2010. Dirección General de Planificación y Evaluación. Dirección de Servicios y Calidad, Servicio Catalán de Salud. Departamento de Salud. Generalidad de Cataluña. Barcelona, 2009.
4. Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: Economic cost and quality of life. Annu Rev Public Health 2001;22:91-113.
5. Two week standar. Department of Health. NHS referral Guidelines for Bowel cancer. London: Association of Coloproctology of Great Britain and Ireland, 2002.
6. Walsh S, Bruce C, Bennington S, Ravi S. The fourteen day rule and colorectal cancer. Ann R Coll Surg Engl 2002;84:386-8.
7. Van Steenberg LN, Lemmens VE, Rutten HJT, Martijn H, Coebergh JWW. Was there shortening of the interval between diagnosis and treatment of colorectal cancer in Southern Netherlands between 2005 and 2008? Word J Surg 2010;34:1071-9.
8. Korsgaard M, Pedersen L, Laurberg S. Delay of diagnosis and treatment of colorectal cancer: a population-based Danish study. Cancer Detect Prev 2008;32:45-51.
9. Referrals guidelines for suspected cancer. Department of Health, London UK; 2000.
10. Ramos M, Esteva M, Cabeza E, Llobera J, Ruiz A. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer 2008;44:510-21.
11. González Hermoso F, Pérez Palma J, Marchena Gómez J, Lorenzo Rocha N, Medina Arana V. Can early diagnosis of symptomatic colo-rectal cancer improve the prognosis. World J Surg 2004;28:716-20.
12. Ley orgánica 15/1999, de 13 de diciembre, de Protección de Datos de Carácter Personal. BOE n. 298 de 14/12/1999.
13. CIE-9. Available at: http://www.msps.es/ecieMaps-2010/basic_search/cie9mc_basic_search.html on line Enero 2011.
14. Eccersley AJ, Wilson EM, Makris A, Novell JR. Referral guidelines for colorectal cancer, do they work? Ann R Coll Surg Engl 2003;85:107-11.
15. Rai S, Kelly MJ. Prioritization of colorectal referrals: a review of the 2-week wait referral system. Colorectal Dis 2007;9:195-202.
16. Flashmman K, O'Leary DP, Senapati A, Thompson MR. The department of Health's "two-week standard" for bowel cancer: is it working? Gut 2004;53:387-91.
17. Thorne K, Hutchings HA. The effects of the Two-Week Rule on NHS colorectal cancer diagnostic services: A systematic literature review. BMC Health Serv Res 2006;6:43.
18. Chohan DPK, Goodwin K, Wilkinson S, Miller R, Hall NR. How has the "two-week wait" rule affected the presentation of colorectal cancer? Colorectal Dis 2005;7:450-3.
19. Aljarabah MM, Borley NR, Goodman AJ, Wheeler JMD. Referral letters for 2-week wait suspected colorectal cancer do not allow a "straight-to-test" pathway. Ann R Coll Surg Eng 2009;91:106-9.
20. Jiwa M, Hamilton W. Referral of suspected colorectal cancer: have guidelines made a difference? Br J Gen Pract 2004;54:608-10.
21. Jiwa M, Saunders C. Fast track referral for cancer. Has not improved patient outcomes in the UK. BMJ 2007;335:267.
22. Leung E, Grainger J, Bandla N, Wong L. The effectiveness of the '2-week wait' referral service for colorectal cancer. Int J Clin Pract 2010;64(12):1671-4.
23. Singh HDK, Daci K, Petersen LA, Collins C, Petersen NJ, Shethia A, et al. Missed opportunities to initiate endoscopic evaluation for colo-rectal cancer diagnosis. Am J Gastroenterol 2009;104(10):2543-54.
24. Neal RD, Allgar VL, Ali N, Leese B, Heywood P, Proctor G, et al. Stage, survival and delays in lung colorectal, prostate and ovarian cancer: comparison between diagnostic routes. BJ Gen Pract 2007;57:212-9.
25. Terhaar sive Droste J, Oort F, van der Hulst R, Coupe V, Craanen M, Meijer G, et al. Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study. BMC Cancer 2010;10:332.
26. Iversen LH, Antonsen S, Laurberg S, Lautrup MD: Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg 2009;96:1183-9.
27. Guzmán Laura KP, Bolíbar Ribas I, Alepuz MT, González D, Martín M. Impact on patient care time and tumor stage of a program for last diagnostic and treatment of colorectal cancer. Rev Esp Enferm Dig 2011;103:13-9.
28. Neal RD. Do diagnostic delays in cancer matter? B J Cancer 2009; 101:S9-12.
29. Fisher D, Zullig L, Grambow L, Abbott D. Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci 2010;55:1434-41.
30. Lejeune C, Sassi F, Ellis L, Godward S, Mak V, Day M, et al. Socio-economic disparities in access to treatment and their impact on colo-rectal cancer survival. Int J Epidemiol 2010;39:710-7.
31. Macleod U, Mitchell ED, Burgess, Macdonald S, Ramirez AJ. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer 2009;101:S92-S101.
32. Hamilton W. Five misconceptions in cancer diagnosis 2009. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688046/ on line. September 2010.
33. Dreyfuss JH. Fecal occult blood testing has great potential as a screening tool for colorectal cancer. CA Cancer J Clin 2010;60:275-6.
34. Ramos M, Esteva M, Almeda J, Cabeza E, Puente D, Saladich R, et al. Knowledge and attitudes of primary health care physicians and nurses with regard to population screening for colorectal cancer in Balearic Islands and Barcelona. BMC 2010;10:500.
35. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colo-rectal cancer. N Engl J Med 2000;343:1603-7.
36. Navarro M, Peris M, Binefa G, Nogueira JM, Miquel JM, Espinás JA, et al; y Grupo Catalán del Programa Piloto en Cribado de Cáncer Colo-rrectal. Colonoscopic findings from a pilot screening study for colorectal cancer in Catalonia. Rev Esp Enferm Dig 2008;100:343-8.
37. Díaz Tasende J, Marín Gabriel C. Colorectal cancer screening with fecal occult blood testing. Rev Esp Enferm Dig 2008;100:315-9.
38. Calcerrada Díaz-Santos N., Valentín López B, Blasco Amaro JA. Aná-lisis coste-efectividad del cribado de cáncer colorrectal en población general. Primera parte: Revisión sistemática sobre su eficacia y segu-ridad. Madrid: Plan de Calidad para el SNS del MSC. Unidad de Eva-luación de Tecnologías Sanitarias, Agencia Laín Entralgo; 2008. Infor-mes de Evaluación de Tecnologías Sanitarias: UETS No 2006/06.